X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (666) 666
Publication (167) 167
Paper (127) 127
Book Chapter (9) 9
Book / eBook (5) 5
Conference Proceeding (3) 3
Book Review (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
nuclear experiment (177) 177
physics (156) 156
experiment (152) 152
nuclear physics (116) 116
high energy physics - experiment (106) 106
melanoma (104) 104
humans (87) 87
high energy physics (83) 83
index medicus (74) 74
oncology (73) 73
particle physics (72) 72
nucl (66) 66
hep (62) 62
fysik (55) 55
natural sciences (55) 55
naturvetenskap (55) 55
physical sciences (55) 55
subatomic physics (55) 55
subatomär fysik (55) 55
transverse momentum (54) 54
immunotherapy (52) 52
physics of elementary particles and fields (51) 51
114 physical sciences (50) 50
physics, particles & fields (49) 49
[phys.nexp]physics [physics]/nuclear experiment [nucl-ex] (48) 48
ex (47) 47
melanoma - drug therapy (46) 46
cern lhc coll (44) 44
cancer (43) 43
[ phys.nexp ] physics [physics]/nuclear experiment [nucl-ex] (42) 42
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (39) 39
male (38) 38
female (37) 37
rapidity (37) 37
heavy ion experiments (36) 36
metastatic melanoma (36) 36
物理学 (36) 36
aged (35) 35
experimental results (35) 35
ipilimumab (35) 35
middle aged (35) 35
lead (32) 32
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (31) 31
alice (31) 31
nuclear and high energy physics (31) 31
physics, nuclear (31) 31
adult (30) 30
heavy ion: scattering (30) 30
care and treatment (28) 28
matematikk og naturvitenskap: 400::fysikk: 430::kjerne- og elementærpartikkelfysikk: 431 [vdp] (28) 28
mathematics and natural scienses: 400::physics: 430::nuclear and elementary particle physics: 431 [vdp] (28) 28
melanoma - pathology (28) 28
elementary particles, quantum field theory (27) 27
quantum field theories, string theory (27) 27
skin neoplasms - drug therapy (26) 26
interferon (25) 25
research (25) 25
survival (25) 25
collisions (23) 23
melanoma - immunology (23) 23
melanoma - therapy (23) 23
monte carlo (23) 23
nuclear physics - experiment (23) 23
skin neoplasms - pathology (23) 23
article (22) 22
astronomy & astrophysics (22) 22
metastasis (22) 22
phenomenology (22) 22
suppression (22) 22
adjuvant therapy (21) 21
physics and astronomy (21) 21
treatment outcome (21) 21
aged, 80 and over (20) 20
chemotherapy (20) 20
malignant-melanoma (20) 20
patients (20) 20
automatic keywords (19) 19
dependence (19) 19
p p: scattering (19) 19
particle physics - experiment (19) 19
drug therapy (18) 18
engineering (18) 18
nuclear and particle physics. atomic energy. radioactivity (18) 18
nuclear energy (18) 18
astronomy, astrophysics and cosmology (17) 17
astrophysics (17) 17
dosage and administration (17) 17
elliptic flow (17) 17
hep-ex (17) 17
immunology (17) 17
measurement science and instrumentation (17) 17
neoplasm staging (17) 17
nuclear physics, heavy ions, hadrons (17) 17
prognosis (17) 17
antineoplastic agents - therapeutic use (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
cooperative-oncology-group (16) 16
health aspects (16) 16
nucl-ex (16) 16
nuclear theory (16) 16
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF HEMATOLOGY & ONCOLOGY, ISSN 1756-8722, 04/2017, Volume 10, Issue 1, pp. 88 - 9
Patients with advanced melanoma have a compromised anti-tumor immune response leading to tumor immune tolerance and a tumor microenvironment conducive to... 
PROGRAMMED CELL-DEATH-1 | DENDRITIC CELLS | Anti-CTLA4 | Melanoma | MONOCLONAL-ANTIBODY | RECOMBINANT INTERLEUKIN-2 | TUMOR-INFILTRATING LYMPHOCYTES | PHASE-III TRIAL | ADOPTIVE CELL THERAPY | METASTATIC MELANOMA | INTERFERON-ALPHA | ONCOLOGY | Immunotherapy | Anti-PD1 | HIGH-DOSE INTERLEUKIN-2 | HEMATOLOGY | CD40 Antigens - antagonists & inhibitors | Humans | Interleukin-2 - therapeutic use | Neoplasm Proteins - immunology | Tumor Microenvironment | Neoplasm Proteins - antagonists & inhibitors | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Receptors, OX40 - immunology | Ipilimumab - therapeutic use | Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology | Interferon-alpha - therapeutic use | Clinical Trials as Topic | CTLA-4 Antigen - immunology | B7-H1 Antigen - immunology | Melanoma - secondary | B7-H1 Antigen - antagonists & inhibitors | Antineoplastic Agents, Immunological - therapeutic use | Tumor Necrosis Factor Receptor Superfamily, Member 9 - antagonists & inhibitors | Biomarkers | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - antagonists & inhibitors | Melanoma - therapy | CD40 Antigens - immunology | Receptors, OX40 - antagonists & inhibitors | Medical research | Antigens | Lymphatic system | Immune response | Cytotoxicity | Metastasis | Gene expression | Immunological tolerance | Survival | Survival analysis | CTLA-4 protein | Immune checkpoint | Interleukin 2 | Lymphocytes | Polyethylene glycol | Monoclonal antibodies | Interferon | Cancer
Journal Article
by Adam, J and Adamov, D and Aggarwal, M.M and Aglieri Rinella, G and Agnello, M and Agrawal, N and Ahammed, Z and Ahmad, S and Ahn, S.U and Aiola, S and Akindinov, A and Alam, S.N and Albuquerque, D.S.D and Aleksandrov, D and Alessandro, B and Alexandre, D and Alfaro Molina, R and Alici, A and Alkin, A and Alme, J and Alt, T and Altinpinar, S and Altsybeev, I and Prado, C. Alves Garcia and An, M and Andrei, C and Andrews, H.A and Andronic, A and Anguelov, V and Anticic, T and Antinori, F and Antonioli, P and Aphecetche, L and Appelshäuser, H and Arcelli, S and Arnaldi, R and Arnold, O.W and Arsene, I.C and Arslandok, M and Audurier, B and Augustinus, A and Averbeck, R and Azmi, M.D and Badalà, A and Baek, Y.W and Bagnasco, S and Bailhache, R and Bala, R and Balasubramanian, S and Baldisseri, A and Baral, R.C and Barbano, A.M and Barbera, R and Barile, F and Barnafldi, G.G and Barnby, L.S and Barret, V and Bartalini, P and Barth, K and Bartke, J and Bartsch, E and Basile, M and Bastid, N and Basu, S and Bathen, B and Batigne, G and Camejo, A. Batista and Batyunya, B and Batzing, P.C and Bearden, I.G and Beck, H and Bedda, C and Behera, N.K and Belikov, I and Bellini, F and Martinez, H. Bello and Bellwied, R and Belmont, R and Belmont-Moreno, E and Beltran, L.G.E and Belyaev, V and Bencedi, G and Beole, S and Berceanu, I and Bercuci, A and Berdnikov, Y and Berenyi, D and Bertens, R.A and Berzano, D and Betev, L and Bhasin, A and Bhat, I.R and Bhati, A.K and Bhattacharjee, B and Bhom, J and Bianchi, L and Bianchi, N and Bianchin, C and Bielcík, J and Bielcíková, J and ... and ALICE Collaboration
Nature Physics, ISSN 1745-2473, 06/2017, Volume 13, Issue 6, pp. 535 - 539
At sufficiently high temperature and energy density, nuclear matter undergoes a transition to a phase in which quarks and gluons are not confined: the... 
P-PB COLLISIONS | BARYON PRODUCTION | SIDE | LONG-RANGE | ENERGY-DEPENDENCE | PPB | PHYSICS, MULTIDISCIPLINARY | MID-RAPIDITY | RANGE ANGULAR-CORRELATIONS | Phenomenology | Hadrons | Pions | Quark-gluon plasma | Collisions | Heavy nuclei | Signatures | Strangeness
Journal Article
Seminars in Oncology, ISSN 0093-7754, 08/2015, Volume 42, Issue 4, pp. 539 - 548
Journal Article
by Acharya, S and Adamová, D and Aggarwal, M.M and Aglieri Rinella, G and Agnello, M and Agrawal, N and Ahammed, Z and Ahmad, N and Ahn, S.U and Aiola, S and Akindinov, A and Alam, S.N and Albuquerque, D.S.D and Aleksandrov, D and Alessandro, B and Alexandre, D and Alfaro Molina, R and Alici, A and Alkin, A and Alme, J and Alt, T and Altsybeev, I and Alves Garcia Prado, C and An, M and Andrei, C and Andrews, H.A and Andronic, A and Anguelov, V and Anson, C and Antičić, T and Antinori, F and Antonioli, P and Anwar, R and Aphecetche, L and Appelshäuser, H and Arcelli, S and Arnaldi, R and Arnold, O.W and Arsene, I.C and Arslandok, M and Audurier, B and Augustinus, A and Averbeck, R and Azmi, M.D and Badalà, A and Baek, Y.W and Bagnasco, S and Bailhache, R and Bala, R and Baldisseri, A and Ball, M and Baral, R.C and Barbano, A.M and Barbera, R and Barile, F and Barioglio, L and Barnaföldi, G.G and Barnby, L.S and Barret, V and Bartalini, P and Barth, K and Bartke, J and Bartsch, E and Basile, M and Bastid, N and Basu, S and Bathen, B and Batigne, G and Batista Camejo, A and Batyunya, B and Batzing, P.C and Bearden, I.G and Beck, H and Bedda, C and Behera, N.K and Belikov, I and Bellini, F and Bello Martinez, H and Bellwied, R and Beltran, L.G.E and Belyaev, V and Bencedi, G and Beole, S and Bercuci, A and Berdnikov, Y and Berenyi, D and Bertens, R.A and Berzano, D and Betev, L and Bhasin, A and Bhat, I.R and Bhati, A.K and Bhattacharjee, B and Bhom, J and Bianchi, L and Bianchi, N and Bianchin, C and Bielčík, J and Bielčíková, J and Bilandzic, A and ... and ALICE Collaboration and Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States) and Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States) and eSSENCE: The e-Science Collaboration and Lund University and Partikelfysik and Lunds universitet and Particle Physics
Physics Letters B, ISSN 0370-2693, 01/2018, Volume 776, Issue C, pp. 249 - 264
This letter presents the first measurement of jet mass in Pb–Pb and p–Pb collisions at TeV and TeV, respectively. Both the jet energy and the jet mass are... 
LARGE TRANSVERSE-MOMENTUM | LEAD COLLISIONS | AU+AU | TEV | ASTRONOMY & ASTROPHYSICS | PHYSICS, NUCLEAR | SUPPRESSION | DEPENDENCE | PHYSICS, PARTICLES & FIELDS | Nuclear Experiment | Physics | CLASSICAL AND QUANTUM MECHANICS, GENERAL PHYSICS | PARTICLE ACCELERATORS | Fysik | Subatomär fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Natural Sciences
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e87705
Journal Article
Journal of Hematology and Oncology, 04/2017, Volume 10, Issue 1
Journal Article
by Acharya, S and Adamová, D and Adolfsson, J and Aggarwal, M M and Aglieri Rinella, G and Agnello, M and Agrawal, N and Ahammed, Z and Ahmad, N and Ahn, S U and Aiola, S and Akindinov, A and Alam, S N and Alba, J L. B and Albuquerque, D S. D and Aleksandrov, D and Alessandro, B and Alfaro Molina, R and Alici, A and Alkin, A and Alme, J and Alt, T and Altenkamper, L and Altsybeev, I and Alves Garcia Prado, C and Andrei, C and Andreou, D and Andrews, H A and Andronic, A and Anguelov, V and Anson, C and Antičić, T and Antinori, F and Antonioli, P and Anwar, R and Aphecetche, L and Appelshäuser, H and Arcelli, S and Arnaldi, R and Arnold, O W and Arsene, I C and Arslandok, M and Audurier, B and Augustinus, A and Averbeck, R and Azmi, M D and Badalà, A and Baek, Y W and Bagnasco, S and Bailhache, R and Bala, R and Baldisseri, A and Ball, M and Baral, R C and Barbano, A M and Barbera, R and Barile, F and Barioglio, L and Barnaföldi, G G and Barnby, L S and Barret, V and Bartalini, P and Barth, K and Bartsch, E and Basile, M and Bastid, N and Basu, S and Bathen, B and Batigne, G and Batyunya, B and Batzing, P C and Bearden, I G and Beck, H and Bedda, C and Behera, N K and Belikov, I and Bellini, F and Bello Martinez, H and Bellwied, R and Beltran, L G. E and Belyaev, V and Bencedi, G and Beole, S and Bercuci, A and Berdnikov, Y and Berenyi, D and Bertens, R A and Berzano, D and Betev, L and Bhasin, A and Bhat, I R and Bhati, A K and Bhattacharjee, B and Bhom, J and Bianchi, L and Bianchi, N and Bianchin, C and Bielčík, J and Bielčíková, J and Bilandzic, A and ... and ALICE Collaboration and The ALICE collaboration and Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Journal of High Energy Physics, ISSN 1126-6708, 9/2017, Volume 2017, Issue 9, pp. 1 - 33
Journal Article
by Adam, J and Adamová, D and Aggarwal, M.M and Aglieri Rinella, G and Agnello, M and Agrawal, N and Ahammed, Z and Ahmad, S and Ahn, S.U and Aiola, S and Akindinov, A and Alam, S.N and Albuquerque, D.S.D and Aleksandrov, D and Alessandro, B and Alexandre, D and Alfaro Molina, R and Alici, A and Alkin, A and Alme, J and Alt, T and Altinpinar, S and Altsybeev, I and Alves Garcia Prado, C and An, M and Andrei, C and Andrews, H.A and Andronic, A and Anguelov, V and Anson, C and Antičić, T and Antinori, F and Antonioli, P and Aphecetche, L and Appelshäuser, H and Arcelli, S and Arnaldi, R and Arnold, O.W and Arsene, I.C and Arslandok, M and Audurier, B and Augustinus, A and Averbeck, R and Azmi, M.D and Badalà, A and Baek, Y.W and Bagnasco, S and Bailhache, R and Bala, R and Balasubramanian, S and Baldisseri, A and Baral, R.C and Barbano, A.M and Barbera, R and Barile, F and Barnaföldi, G.G and Barnby, L.S and Barret, V and Bartalini, P and Barth, K and Bartke, J and Bartsch, E and Basile, M and Bastid, N and Basu, S and Bathen, B and Batigne, G and Batista Camejo, A and Batyunya, B and Batzing, P.C and Bearden, I.G and Beck, H and Bedda, C and Behera, N.K and Belikov, I and Bellini, F and Bello Martinez, H and Bellwied, R and Belmont-Moreno, E and Beltran, L.G.E and Belyaev, V and Bencedi, G and Beole, S and Berceanu, I and Bercuci, A and Berdnikov, Y and Berenyi, D and Bertens, R.A and Berzano, D and Betev, L and Bhasin, A and Bhat, I.R and Bhati, A.K and Bhattacharjee, B and Bhom, J and Bianchi, L and Bianchi, N and Bianchin, C and Bielčík, J and Bielčíková, J and ... and ALICE Collaboration and Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States) and Lund University and Partikelfysik and Lunds universitet and Particle Physics
Physics Letters B, ISSN 0370-2693, 12/2016, Volume 763, Issue C, pp. 238 - 250
Journal Article
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 09/2012, Volume 62, Issue 5, pp. 309 - 335
The immunotherapy of cancer has made significant strides in the past few years due to improved understanding of the underlying principles of tumor biology and... 
PHASE-III TRIAL | TUMOR-INFILTRATING LYMPHOCYTES | HIGH-RISK MELANOMA | ANTI-CD40 MONOCLONAL-ANTIBODY | METASTATIC MALIGNANT-MELANOMA | PULSED DENDRITIC CELLS | COLONY-STIMULATING FACTOR | ONCOLOGY | HEPATOCELLULAR-CARCINOMA PATIENTS | CD8(+) T-CELLS | RECOMBINANT INTERLEUKIN-2 THERAPY | Immunotherapy - methods | Dendritic Cells - immunology | Humans | Dendritic Cells - physiology | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Cancer Vaccines - therapeutic use | Neoplasms - therapy | Immunotherapy - trends | Angiogenesis Inhibitors - therapeutic use | Receptor, ErbB-2 - antagonists & inhibitors | Cetuximab | Yttrium Radioisotopes - therapeutic use | Gene Transfer Techniques | Histocompatibility Antigens - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Vaccines, DNA - therapeutic use | alpha-Fetoproteins - therapeutic use | alpha-Fetoproteins - immunology | Neoplasms - immunology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - antagonists & inhibitors | Receptor, Epidermal Growth Factor - antagonists & inhibitors | T-Lymphocytes - immunology | Genetic Vectors | Trastuzumab | Care and treatment | Usage | Research | Health aspects | Immunotherapy | Cancer | Immunology | Cancer therapies | Manipulation | Tumors
Journal Article